Skip to content
GLP-1 Savers

Head-to-head · Value Score

Embody vs REMEVi

Two GLP-1 deals, scored on the same six factors. Embody lands a Value Score of 85, REMEVi a 89. Compare their advertised prices, billing terms, and what to check before paying.

By Grant Ashford, Founder & Pricing Editor

Embody

Grade A- · Great Deal

Advertised price

$79/mo month-to-month

$79/mo month-to-month ($49/mo on the 12-month bundle, all doses, compounded)

Get this deal Full Embody review →
VS
★ Better value

REMEVi

Grade A · Great Deal

Advertised price

$143/mo month-to-month

$143/mo month-to-month ($96/mo on the 12-month plan, compounded)

Get this deal Full REMEVi review →

The verdict

Better value: REMEVi

REMEVi takes it on Value Score, 89 to 85 — at an advertised price of $143/mo month-to-month ($96/mo on the 12-month plan, compounded). Check the pricing terms before enrolling. Embody isn't out of it: Shoppers who want one compounded price at every dose, published as a full ladder from month-to-month to a 12-month bundle.

Featured partner:CoreAge Rx, advertised prices with checkout conditions (Value Score 81).Read the review →

If neither program settles it, the Belle Health review and the Eden review cover two other programs we partner with, and each sets out its price and billing terms so you can run the same comparison.

Deal-by-deal

The numbers that decide it. Green ✓ marks the stronger side on each line.

DealEmbodyREMEVi
Value Score85 (A-)89 (A)
Advertised price$79/mo month-to-month ($49/mo on the 12-month bundle, all doses, compounded)$143/mo month-to-month ($96/mo on the 12-month plan, compounded)
Save vs brand self-pay——
Semaglutide$79/mo month-to-month ($49/mo on the 12-month bundle, all doses, compounded)$143/mo month-to-month ($96/mo on the 12-month plan, compounded)
Tirzepatide$129/mo month-to-month ($99/mo on the 12-month bundle, all doses, compounded)$224/mo month-to-month ($168/mo on the 12-month plan, compounded)
Both moleculesYesYes
PricingWatchWatch
CoverageAll 50 statesAll 50 states

Factor by factor

The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.

Lowest Real Price
Embody: 90. REMEVi: 82.
No Teaser-Rate Bait
Embody: 80. REMEVi: 90.
Nationwide Availability
Embody: 96. REMEVi: 96.
Both Molecules
Embody: 98. REMEVi: 98.
Easy Cancellation
Embody: 62. REMEVi: 95.
Reputation
Embody: 68. REMEVi: 87.

Embody

Embody offers compounded semaglutide and tirzepatide via injection plus a unique compounded oral tirzepatide gum formulation.

What's good

  • Among the lowest compounded prices tracked here, and the same at every dose: $79 a month for semaglutide and $129 for tirzepatide billed monthly, per Embody's own terms
  • Unique compounded oral tirzepatide gum formulation — alternative for patients who prefer not to inject
  • Available in all 50 states with no insurance friction
  • 24/7 unlimited clinician messaging and dose-adjustment support included
  • Medical leadership by Dr. Alan Viglione, board-certified in Internal Medicine

The fine print

  • The $49 and $99 homepage headlines are 12-month bundle rates; billed monthly the same products are $79 and $129, and a 'save $200' sale banner sits beside them
  • Compounded only — no FDA-approved brand-name Ozempic, Wegovy, Zepbound, or Mounjaro option
  • Pharmacy partners not publicly named — compounding source transparency is limited
  • Compounded oral tirzepatide does not have an FDA-approved counterpart, and oral GLP-1 bioavailability remains an active area of clinical debate

REMEVi

REMEVi is the first bilingual (English and Spanish) GLP-1 telehealth clinic — care delivered by clinicians trained in both languages, never auto-translated.

What's good

  • A genuinely flat rate: 'the same price at every dose', stated as such, with no dose upcharge and no introductory rate to step off
  • Longer terms are published openly in one plan table rather than used as a teaser - semaglutide is $143 monthly, $125 on 3 months, $118 on 6 and $96 on 12
  • A daily oral semaglutide tablet is offered alongside the injection
  • Available in all 50 states and DC, with no minimum commitment and no cancellation fee

The fine print

  • The lowest figures need a full 12-month plan: semaglutide is $96 there against $143 month-to-month, and tirzepatide $168 against $224
  • No FDA-approved brand-name pathway — the Wegovy and Ozempic pages are comparison content, not products
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products
Get the Embody deal Get the REMEVi deal

We earn a commission when you start treatment through some links on this site, at no extra cost to you. It never changes a Value Score.

Neither one the right fit? Every program that outscores Embody is ranked on the Embody alternatives ranking, and the same list for the other side is on alternatives to REMEVi.

More head-to-heads

The programs scoring closest to this pair, side by side.

← All comparisons

Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. "% vs brand-name self-pay" compares a program's lowest disclosed monthly price against $349/mo, Wegovy's self-pay price at NovoCare Pharmacy, every standard dose after the two-month intro offer (checked October 2026). Prices change — confirm on each provider's site. Not medical advice; see our disclosure.